The effect of intravesical instillations with Hyaluronic Acid on sexual dysfunction in women with recurrent urinary tract infections (RUTI)

被引:5
|
作者
Nightingale, Gemma [1 ]
Shehab, Qasem [1 ]
Kandiah, Chandrakumaran [1 ]
Rush, Lorraine [1 ]
Rowe-Jones, Clare [1 ]
Phillips, Christian H. [1 ]
机构
[1] Univ Winchester, Basingstoke & North Hampshire Hosp, Basingstoke, Hants, England
关键词
Recurrent urinary tract infections; Sexual dysfunction; Hyaluronic acid; BACTERIAL CYSTITIS; GLOBAL IMPRESSION; VALIDATION; INCONTINENCE;
D O I
10.1016/j.ejogrb.2017.12.029
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine whether sexual dysfunction in women with recurrent urinary tract infections (RUTI) improved following treatment with intravesical Hyaluronic Acid (HA) instillations. Study design: Ethical approval was obtained for a prospective study to be performed. Patients referred for bladder instillations to treat RUTI, and who were sexually active, were recruited to the study. A selection of validated questionnaires (ICIQ-UI, ICIQ-VS, FSDS-R, ICIQ-FLUTS, O'Leary/Sant and PGI-I) were completed at baseline, three, six and 12 months after initiation of treatment with bladder instillations. Treatment consisted of weekly bladder instillations with a preparation containing HA for four weeks then monthly for two further treatments. Results were populated in SPSS for statistical analysis and statistical significance was powered for 22 patients. Results: Thirty women were included in the study. FSDS-R was used to determine sexual dysfunction and showed that 57% patients with RUTI had significant sexual distress. There was a significant improvement in FSDS-R at three, six and 12 months when compared to baseline (Friedman two-way analysis p < 0.001). ICIQ FLUTS F and I scores, O'Leary/Sant, ICIQ VS and PGI-I also showed a statistically significant improvement throughout the period of follow up. A statistically significant, negative correlation was found between FSDS-R and PGI-I at 12 months (r = -0.468, p = 0.009). Conclusion: We have reinforced previous work showing the association between RUTI and sexual dysfunction, and an improvement in bladder symptoms following treatment with HA. To our knowledge, this is the first study to prove an improvement in sexual dysfunction following intravesical treatment with HA which is sustained for up to 12 months. Crown Copyright (C) 2017 Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 108
页数:4
相关论文
共 50 条
  • [1] Intravesical instillations for the treatment of refractory recurrent urinary tract infections
    Dutta, Sonia
    Lane, Felicia
    THERAPEUTIC ADVANCES IN UROLOGY, 2018, 10 (05) : 157 - 163
  • [2] Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid
    Lipovac, M.
    Kurz, C.
    Reithmayr, F.
    Verhoeven, H. C.
    Huber, J. C.
    Imhof, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2007, 96 (03) : 192 - 195
  • [3] Intravesical hyaluronic acid treatment in recurrent urinary tract infections in children with spina bifida and neurogenic bladder
    Cicek, Neslihan
    Yildiz, Nurdan
    Alpay, Harika
    JOURNAL OF PEDIATRIC UROLOGY, 2020, 16 (03) : 366.e1 - 366.e5
  • [4] Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis
    Goddard, Jonathan Charles
    Janssen, Dick A. W.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2018, 29 (07) : 933 - 942
  • [5] The use of intravesical hyaluronic acid for recurrent urinary tract infections in children: a case-series study
    Fidan, Kibriya
    Buyukkaragoz, Bahar
    Ozen, Onur
    Demirogullari, Billur
    Soylemezoglu, Oguz
    RENAL FAILURE, 2015, 37 (10) : 354 - 358
  • [6] Management of recurrent urinary tract infections in women
    Sihra, Neha
    Malde, Sachin
    Greenwell, Tamsin
    Pakzad, Mahreen
    Kujawa, Magda
    Sinclair, Andrew
    JOURNAL OF CLINICAL UROLOGY, 2022, 15 (02) : 152 - 164
  • [7] Prevention of Recurrent Urinary Tract Infections by Intravesical Administration of Hyaluronic Acid and Chondroitin Sulphate: A Placebo-Controlled Randomised Trial
    Damiano, Rocco
    Quarto, Giuseppe
    Bava, Ilaria
    Ucciero, Giuseppe
    De Domenico, Renato
    Palumbo, Michele I.
    Autorino, Riccardo
    EUROPEAN UROLOGY, 2011, 59 (04) : 645 - 651
  • [8] Intravesical hyaluronic acid and chondroitin sulfate for recurrent urinary tract infections: systematic review and meta-analysis
    Jonathan Charles Goddard
    Dick A. W. Janssen
    International Urogynecology Journal, 2018, 29 : 933 - 942
  • [9] Intravesical Agents for Prevention of Recurrent Urinary Tract Infections
    Ochoa, D. Carolina
    Healy, Rion
    EUROPEAN UROLOGY FOCUS, 2024, 10 (05): : 726 - 730
  • [10] Orally Administered Combination of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin in the Prevention of Postcoital Recurrent Urinary Tract Infections: Analysis of 98 Women in Reproductive Age After 6 Months of Treatment
    Schiavi, Michele Carlo
    Porpora, Maria Grazia
    Vena, Flaminia
    Prata, Giovanni
    Sciuga, Valentina
    D'Oria, Ottavia
    Di Tucci, Chiara
    Savone, Delia
    Aleksa, Natalia
    Giannini, Andrea
    Nusiner, Maria Paola
    Zullo, Marzio Angelo
    Muzii, Ludovico
    Panici, Pierluigi Benedetti
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2019, 25 (04): : 309 - 312